The Country Coordinating Mechanism (CCM) evolution initiative aims to strengthen CCMs’ performance in four areas: their internal functioning, oversight of the grants, engagement between the CCM and its constituency members, and linkages with other national governance bodies.
You are here
Global Fund Country Coordinating Mechanism evolution initiative: Mid-term lessons from Tanzania, Niger, Uganda and Burundi
On 31 January 2019, the Global Fund Board approved three country grants worth $13.4 million. It also approved two multicountry grants valued at $22.5 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). See Tables 1 and 2 for listings of the country and multi-country grants.
Three countries, three different applications of co-financing in Global Fund grants in sub-Saharan Africa
In the beginning, there was performance-based funding. It was the outcomes-based mechanism of choice for the Global Fund and forms the foundation on which the Global Fund’s grant architecture was built. The idea was simple. Release funding in tranches, whereby recipients were required to reach specific targets before the rest of the grant would be disbursed.
Global Fund multi-country program in East Africa spearheads trip to China to learn about harm reduction technologies
TRP praises Uganda’s TB/HIV funding request to the Global Fund, but sends two matching funds requests back for iteration
In its review of Uganda’s TB/HIV funding request, the Technical Review Panel (TRP) praised the country for positioning the request as part of a more sustainable response, including a push to improve coordination with the private sector, and for scaling up interventions for key populations.
Findings conducted by The Observer, a Kampala based newspaper, indicate that instances of expired medicines and health supplies in Uganda is still rampant, and that expired drugs were still on the shelves at various health facilities during a recent survey conducted by the newspaper.
On 3 August 2016, the Board approved additional funding of $37 million to ensure that all essential services for a shortened HIV grant to Uganda can be provided through to 31 December 2017. The money will come from the $700 million which the Fund has identified as being available for portfolio optimization. The Board was acting on recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC).
For the second time in a month, the Office of the Inspector General has released a report of an audit into grants to a major recipient of Global Fund money that revealed serious deficiencies in the way the grants have been managed. First, it was Tanzania (see GFO article); this time, it is Uganda.
In January, in response to a shortage of antiretrovirals in Uganda, The Global Fund Secretariat arranged to procure a supply of the drugs. In addition, as a precautionary measure, the Secretariat is providing Uganda with a full year’s supply of drugs, the first batch of which is expected to arrive in March. This comes as a relief to the 241,000 Ugandans who are receiving ARVs purchased with money from The Global Fund.